Mylan Laboratories Limited

Grantee website Hyderabad, India
Purpose
to co-formulate Tenofovir Disoproxil Fumarate/Emtricitabine or Emtricitabine/ Tenofovir Alafenamide with a hormone as a dual oral pill for HIV and pregnancy prevention
Division
Global Health
Date
NOVEMBER 2019
Region served
GLOBAL
Committed amount
$2,558,312
Grant topic
HIV
Duration (months)
68
Grantee location
Hyderabad, India
Program strategy page

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.